Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil O Carragher

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
ACS Omega|March 3, 2025
Cellular Activity of CQWW Nullomer-Derived PeptidesSteven Shave, Rebecka Isaksson, Nhan T Pham, et al.
Molecular Cancer Therapeutics|June 10, 2010
High-content phenotypic profiling of drug response signatures across distinct cancer cellsPeter D Caie, Rebecca E Walls, Alexandra Ingleston-Orme, et al.
RSC Medicinal Chemistry|December 15, 2023
Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cellsDaniel J Baillache, Teresa Valero, Álvaro Lorente-Macías, et al.
Molecular Oncology|December 2, 2021
Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatmentJohn C Dawson, Alison Munro, Kenneth Macleod, et al.
Iscience|February 25, 2025
Single-cell morphological tracking of cell states to identify small-molecule modulators of liver differentiationRebecca E Graham, Runshi Zheng, Jesko Wagner, et al.
Metallomics : Integrated Biometal Science|November 14, 2017
Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of actionJessica M Hearn, George M Hughes, Isolda Romero-Canelón, et al.
Iscience|July 24, 2023
Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cellsPaschalis Athanasiadis, Balaguru Ravikumar, Richard J R Elliott, et al.
Scientific Reports|December 15, 2020
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapiesAdam Byron, Stephan Bernhardt, Bérèngere Ouine, et al.
Digital Discovery|May 20, 2026
Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular modelsVanessa Smer-Barreto, Richard J R Elliott, John C Dawson, et al.
Experimental Eye Research|June 27, 2020
The retinal tyrosine kinome of diabetic Akimba mice highlights potential for specific Src family kinase inhibition in retinal vascular diseaseJurgen Sergeys, Inge Van Hove, Tjing-Tjing Hu, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
ACS Omega|March 3, 2025
Cellular Activity of CQWW Nullomer-Derived PeptidesSteven Shave, Rebecka Isaksson, Nhan T Pham, et al.
Molecular Cancer Therapeutics|June 10, 2010
High-content phenotypic profiling of drug response signatures across distinct cancer cellsPeter D Caie, Rebecca E Walls, Alexandra Ingleston-Orme, et al.
RSC Medicinal Chemistry|December 15, 2023
Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cellsDaniel J Baillache, Teresa Valero, Álvaro Lorente-Macías, et al.
Molecular Oncology|December 2, 2021
Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatmentJohn C Dawson, Alison Munro, Kenneth Macleod, et al.
Iscience|February 25, 2025
Single-cell morphological tracking of cell states to identify small-molecule modulators of liver differentiationRebecca E Graham, Runshi Zheng, Jesko Wagner, et al.
Metallomics : Integrated Biometal Science|November 14, 2017
Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of actionJessica M Hearn, George M Hughes, Isolda Romero-Canelón, et al.
Iscience|July 24, 2023
Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cellsPaschalis Athanasiadis, Balaguru Ravikumar, Richard J R Elliott, et al.
Scientific Reports|December 15, 2020
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapiesAdam Byron, Stephan Bernhardt, Bérèngere Ouine, et al.
Digital Discovery|May 20, 2026
Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular modelsVanessa Smer-Barreto, Richard J R Elliott, John C Dawson, et al.
Experimental Eye Research|June 27, 2020
The retinal tyrosine kinome of diabetic Akimba mice highlights potential for specific Src family kinase inhibition in retinal vascular diseaseJurgen Sergeys, Inge Van Hove, Tjing-Tjing Hu, et al.
Pageof 12